TREVENA INC
Small-molecule therapeutics for central nervous system disorders
- Sector
- Biotech
- Headquarters
- KING OF PRUSSIA, PA
- Founded
- 2007
- Latest Form D
- $60M, May 2013
- Total capital
- $77.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $77.5M
- 2 Form D · last May 2013
- 161 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 24
- 16 pending · first 2014
- Rank in peer group#71 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$60M
- Private capital raisedForm D · SEC · 1st filing$17.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#71 · top 5%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Christopher MirabelliDirectorNamed in SEC Form D filings
- David SolomonDirectorNamed in SEC Form D filings
- Farah ChampsiDirectorNamed in SEC Form D filings
- Lonnie Moulder, Jr.DirectorNamed in SEC Form D filings
- Maxine GowenExecutive Officer, DirectorNamed in SEC Form D filings
- Ralph SnydermanDirectorNamed in SEC Form D filings
Show all 9 people
- Robert GarlandDirectorNamed in SEC Form D filings
- Robert, Jr. RuffoloDirectorNamed in SEC Form D filings
- Terence McGuireDirectorNamed in SEC Form D filings
What it has protected
USPTO · 24 granted of 40- GrantedCompounds And Methods Of Preparing Compounds S1P1 ModulatorsUSPTOUS 12,686,675
- GrantedCrystalline And Amorphous Forms Of A Delta-opioid ModulatorUSPTOUS 12,679,825
- GrantedOpioid Receptor Ligands And Methods Of Using And Making SameUSPTOUS 11,931,350
Show all 40 patent records
- Compounds And Methods Of Preparing Compounds S1P1 ModulatorsJul 21, 2026 · US 12,686,675Granted
- Crystalline And Amorphous Forms Of A Delta-opioid ModulatorJul 14, 2026 · US 12,679,825Granted
- Opioid Receptor Ligands And Methods Of Using And Making SameMar 19, 2024 · US 11,931,350Granted
- Compounds For Modulating S1P1 Activity And Methods Of Using The SameFeb 27, 2024 · US 11,912,693Granted
- 7-MEMBERED Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The SameFeb 27, 2024 · US 11,912,713Granted
- Compounds And Methods Of Preparing Compounds S1P1 ModulatorsJan 30, 2024 · US 11,884,655Granted
- Beta-Arrestin Effectors and Compositions and Methods of Use ThereofJan 25, 2024 · Application 17936956Pending
- 5-MEMBERED Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The SameSep 28, 2023 · Application 18314913Pending
- Compounds For Modulating S1P1 Activity And Methods Of Using The SameJul 27, 2023 · Application 18296018Pending
- 5-MEMBERED Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The SameJul 18, 2023 · US 11,702,408Granted
- 6-MEMBERED Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The SameJun 29, 2023 · Application 17879923Pending
- Methods Of Treating Epilepsy Using The SameApr 13, 2023 · Application 17639401Pending
- 6-MEMBERED Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The SameOct 11, 2022 · US 11,465,980Granted
- 7-MEMBERED Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The SameJan 18, 2022 · US 11,225,487Granted
- Beta-Arrestin Effectors and Compositions and Methods of Use ThereofOct 21, 2021 · Application 17235254Pending
- Opioid Receptor Ligands And Methods Of Using And Making SameAug 3, 2021 · US 11,077,098Granted
- Methods of Treating HyperalgesiaJan 28, 2021 · Application 16801567Pending
- Methods of Treating HyperalgesiaMar 17, 2020 · US 10,588,889Granted
- Opioid Receptor Ligands And Methods Of Using And Making SameMar 17, 2020 · US 10,588,898Granted
- 6-MEMBERED Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The SameApr 2, 2019 · US 10,246,436Granted
- Combinations Of Opioid Receptor Ligands And Cytochrome P450 InhibitorsJan 10, 2019 · Application 16064783Pending
- Synthesis of Beta-Arrestin EffectorsJan 18, 2018 · Application 15436214Pending
- Opioid Receptor Ligands And Methods Of Using And Making SameDec 26, 2017 · US 9,849,119Granted
- Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofOct 19, 2017 · Application 15369067Pending
- Crystalline And Amorphous Forms Of A Beta-Arrestin EffectorOct 5, 2017 · Application 15345234Pending
- Opioid Receptor Ligands And Methods Of Using And Making SameMay 9, 2017 · US 9,642,842Granted
- Synthesis of Beta-Arrestin EffectorsApr 4, 2017 · US 9,611,293Granted
- Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofJan 3, 2017 · US 9,534,017Granted
- Crystalline And Amorphous Forms Of A Beta-arrestin EffectorDec 13, 2016 · US 9,518,086Granted
- Opioid Receptor Ligands And Methods Of Using And Making SameApr 12, 2016 · US 9,309,234Granted
- Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofJun 18, 2015 · Application 14631461Pending
- Opioid Receptor Ligands and Methods of Using and Making SameJun 2, 2015 · US 9,044,469Granted
- Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofApr 16, 2015 · Application 14579956Pending
- Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofMar 31, 2015 · US 8,993,511Granted
- Beta-Arrestin Effectors and Compositions and Methods of Use ThereofFeb 3, 2015 · US 8,946,142Granted
- Beta-arrestin Effectors And Compositions And Methods Of Use ThereofAug 19, 2014 · US 8,809,260Granted
- Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofAug 5, 2014 · US 8,796,204Granted
- Methods Of Treating HyperalgesiaApplication PCTUS2016066601Pending
- Compounds And Methods Of Treating Epilepsy Using The SameApplication 62896116Pending
- 6-MEMBERED Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The SameApplication PCTUS2016049526Pending
Related companies, and why
- AUKERA, INC.Similar federal contract value in Biotech · null in contracts
- Vivodyne, Inc.Similar federal contract value in Biotech · null in contracts
- PharmaCyte Biotech, Inc.Similar federal contract value in Biotech · null in contracts
- LifeCyte Innovations, Inc.Similar federal contract value in Biotech · null in contracts
- Revalesio CorpSimilar federal contract value in Biotech · null in contracts
- Triumvira Immunologics Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .